Healthcare Innovation

Healthcare Innovation

Healthcare innovation has been a mixed bag, and for the investor, embarrassingly faddish

In this review of ETFs, profiles are more diverse than their names suggest, with some funds putting emphasis on new fields of medical expertise centered on genomics and often still at the research stage, others on the more broadly defined biotechnology segment, and finally some on applied technology (IT) as new up-and-coming investor darling 

Under the guise of 'diversification', there appears to be uncertainty about the most promising trends and realistic assessment of revenue streams derived from discoveries (often still at clinical stage)

One arguably significant ETF - in terms of assets under management (AUM) -  set aside in this selection is ARK Invest Genomic Revolution because of the fund’s extreme volatility, reflecting its exclusive exposure to 21st century ambitions (or dreams)

Successful investment strategies in the health sector may temper the optimism of medical breakthroughs and of transformative IT applications with hard questions about the financial value added, as our forthcoming notes will discuss

Healthcare Innovation • Updated:

Name Ticker Exchange Category SubCategory Currency Cur.Price AUM Perf. Momentum Vol. Risk Contrib. MDD
ALPS Medical Breakthroughs SBIO NYSEARCA Health Care Research Advance USD 49.14 216 M 15.2% Neutral 32%   10% -31%
ETFMG Treatments Testing and Advancements ETF GERM NYSEARCA Health Care Diagnostics USD 37.94 - 50.9% Weak Up 36%   10% -24%
Franklin Genomic Advancements ETF HELX BATS Health Care Research Advance USD 46.45 - 53.8% Weak Up 32%   10% -26%
Global X Genomics & Biotechnology ETF GNOM NASDAQ Health Care Research Advance USD 22.81 - 33.8% Weak Up 36%   12% -29%
Global X Telemedicine & Digital Health ETF EDOC NASDAQ Health Care IT-supported Health Care USD 18.85 - 21.1% Neutral 23%   7% -31%
Invesco Dynamic Biotechnology & Genome ETF PBE NYSEARCA Health Care Biotech USD 76.87 213 M 36.7% Neutral 28%   9% -18%
iShares Genomics Immunology and Healthcare ETF IDNA NYSEARCA Health Care Research Advance USD 48.36 - 32.6% Weak Up 31%   11% -22%
Loncar Cancer Immunotherapy ETF CNCR NASDAQ Health Care Biotech USD 31.09 38 M 18.8% Neutral 31%   10% -22%
Loncar China BioPharma ETF CHNA NASDAQ China Investable Market USD 44.03 - 49.9% Neutral 27%   6% -17%
ROBO Global® Healthcare Technology and Innovation ETF HTEC NYSEARCA Health Care Research Advance USD 46.68 - 55.4% Neutral 23%   8% -20%
Virtus LifeSci Biotech Products ETF BBP NYSEARCA Health Care Biotech USD 53.79 25 M 15.3% Neutral 26%   8% -17%